March of Dimes
This article was originally published in The Tan Sheet
Executive Summary
Lovastatin should not be switched over the counter "until there are more data on its safety in pregnancy," according to March of Dimes Medical Director Nancy Green, MD. Green notes that "some published data suggest lovastatin may be teratogenic," and that "widespread public recognition of statins may increase the likelihood of statin use during pregnancy." The FDA advisory panels discussed the pregnancy issue during their Jan. 13-14 meeting...